Premarket Movers Sept 25, 2026: INLF, MGLD, AIFF

INLF — INLIF Ltd (+119.2%)

INLIF Ltd is surging more than 119% in Friday's premarket, trading at $6.38 on a staggering 27.67 million shares — that's more than 625 times its 20-day average volume of just 44,253. For a company with a market cap of only $40.2 million, that kind of volume is seismic.

Why it's moving: The catalyst is clear-cut. On September 24, INLIF reported its first-half fiscal-year 2026 financial results, and the numbers were a decisive positive surprise. According to Benzinga and multiple financial outlets, EPS turned positive — hitting $10.01 — while revenue rose 26% year-over-year. A strong earnings beat that flips a company to profitability is one of the most powerful short-term catalysts in the market; it tends to force short sellers (traders who bet the stock will fall) to quickly cover their positions, amplifying the upward move.

Adding context, shareholders had already approved a major capital restructuring and a move to the British Virgin Islands as recently as September 20 — a sign of ongoing corporate transformation that may have put the name on active traders' radar heading into results.

The technical picture: StockSetups' scan carried INLF into this morning with a conviction score of just 4/100, a grade of D, and a deeply bearish MA (moving average) stack — the prior-day chart showed the stock sitting at its 52-week low, with RSI (Relative Strength Index, a momentum gauge on a 0–100 scale) at a historically oversold 23. A free float of just 0.4% — meaning only 0.4% of shares are available to trade publicly — makes even modest buying demand produce explosive price swings. The squeeze score is a modest 15/100, and short interest is minimal at 8,817 shares, so this is less a classic short squeeze and more a pure fundamental-catalyst explosion on an ultra-thin float.

At $40 million market cap and with virtually no float, INLF is an extremely high-risk name even in the context of this premarket list. Moves of this magnitude on thin float stocks can reverse just as violently once regular-session liquidity arrives.

MGLD — Marygold Companies, Inc. (+90.3%)

The Marygold Companies is up 90.3% to $1.94 in premarket trading on volume of 10.66 million shares — nearly 596 times its 20-day average of 17,904. This is a textbook acquisition gap: a stock that institutional money had largely ignored suddenly becoming the target of a major buyout.

Why it's moving: Madison Dearborn Partners — a large private equity firm — announced a definitive agreement to acquire The Marygold Companies, according to Yahoo Finance this morning. A "definitive agreement" means both boards have signed off; it's not a rumor or exploratory talk. In acquisition scenarios, acquirers typically offer a significant premium to the stock's last trade price, which immediately reprices shares toward that deal value. Marygold also filed related proxy documents (DEFA14A, DEF 14A) on September 23–24, consistent with a deal requiring shareholder approval. Separately, Marygold's subsidiary Gourmet Foods announced a definitive agreement to sell its Printstock business unit — asset sales can be part of the broader deal preparation process.

The technical picture: Heading into this morning, MGLD's daily chart showed a bearish MA stack and was sitting 21.6% below its 52-week high, with an RSI of 51 — neutral momentum. The setup carried no bullish chart signal; conviction was 11/100, grade D. But technical picture is almost irrelevant when a company announces it is being taken private: the deal, not chart patterns, becomes the dominant pricing mechanism.

The free float is 24.1% (roughly $10 million worth of shares available to trade), and days to cover — how many days it would take short sellers to buy back their borrowed shares at average volume — is 5.6. That means short sellers scrambling to cover this morning could add fuel to the move on top of the acquisition premium. This is still a small-cap name at $43.5 million pre-news market cap; deal terms, closing conditions, and timing all carry risk.

AIFF — Firefly Neuroscience, Inc. (+37.0%)

Firefly Neuroscience is jumping 37% to $1.63 premarket on enormous volume: 54.37 million shares versus a 20-day average of just 750,570 — roughly 72 times normal. It's already appeared in our coverage before: AIFF was one of the top movers on September 17, so this is a name traders have been watching closely.

Why it's moving: According to Quiver Quantitative and Yahoo Finance this morning, Firefly Neuroscience and NeuroSigma have announced a partnership to expand access to the FDA-cleared Monarch eTNS System — the first FDA-cleared, non-drug treatment for pediatric ADHD. A partnership that expands the commercial footprint of an already-approved medical device is a genuine business catalyst, especially for a micro-cap healthcare-tech name where distribution deals can materially move the revenue needle.

The technical picture: StockSetups' prior-day scan flagged a bullish harami candlestick — a two-candle reversal pattern where a small green candle forms inside the prior day's red candle, signaling potential buying interest. RSI was 55, a modestly positive reading. The MA stack was mixed. Conviction was 23/100, grade D, but the squeeze score of 51/100 is meaningful. With short-volume at 76% — meaning 76% of yesterday's trading was on the short side — and 5.6 days to cover, any sustained buying can force a cascade of short covering. A "short squeeze" occurs when traders who borrowed and sold shares are forced to buy them back quickly as prices rise, magnifying the move. The stock remains 61% below its 52-week high, underlining how much ground has already been lost.

JAGX — Jaguar Health, Inc. (+33.7%)

Jaguar Health is up 33.7% to $9.24 premarket on 6.77 million shares — about 3.2 times its 20-day average of 2.13 million. The Short-Sale Restriction (SSR) is active on JAGX this morning, meaning regulators have restricted certain short-selling activity after the stock fell more than 10% the prior session. SSR can reduce selling pressure temporarily, which often helps bounces.

Why it's moving: Context here is everything. The catalyst for today's bounce is largely technical and mechanical — JAGX is recovering from an extreme two-day collapse. On September 23, the stock plunged 59%, and on September 24, it fell an additional 25% after the company priced an upsized follow-on stock offering and filed 8-Ks disclosing unregistered equity sales, both of which are dilutive events (they increase the share count, reducing existing shareholders' ownership percentage). After a combined decline of that magnitude, it is common for a stock to see a sharp short-term bounce — often called a "dead-cat bounce" — driven by traders covering short positions and bargain hunters speculating on oversold conditions.

The technical picture: INLF entered this morning with a conviction score of 4/100, grade D, a bearish MA stack, and an RSI of 48. Most striking: JAGX is 99.2% below its 52-week high — a sign of catastrophic prior destruction. Short-volume was 61% yesterday, and SSR being triggered confirms the severity of the prior decline. With a $1.2 billion market cap, JAGX is the largest name on this morning's list, but its extreme dilution history and near-zero RS rating (1 out of 99) make it a high-risk bounce candidate, not a recovery story. The 424B5 and 8-K filings from September 24 are bearish structural events that do not disappear because the stock bounces one morning.

APUS — Apimeds Pharmaceuticals US, Inc. (+30.6%)

Apimeds Pharmaceuticals is up 30.6% to $6.65 premarket on 9.63 million shares — 4.4 times its 20-day average of 2.2 million. APUS has been an active trader favorite all week: it was a top mover in both the September 24 after-close recap and the September 24 premarket recap.

Why it's moving: No specific fundamental catalyst has been identified from this morning's available sources. Headlines from StocksToTrade, timothysykes.com, and Benzinga describe the move in terms of trader momentum and volatility rather than pointing to a specific news event. RTT News lists it as a morning market mover alongside other momentum names. This appears to be a continuation momentum move — traders who have followed APUS all week are piling in again on technical and sentiment momentum rather than fresh news. When no clear catalyst exists, the honest read is: this is momentum-driven.

The technical picture: The prior-day chart is notable for a gap of +205.2% — APUS had already gapped massively in a prior session, and the daily chart heading into today showed RSI at 69 (approaching overbought territory, where readings above 70 can signal a pullback risk) with a mixed MA stack. The 52-week high gap is still -85.5%, meaning even after recent gains the stock is far below its prior peak. The conviction score of 38/100 is the highest on this morning's list, and the grade is D. The free float is 54.4% with minimal short interest (0.1 days to cover), so there is little short-squeeze fuel here — this is pure price momentum. Parabolic moves without a hard catalyst are the most prone to rapid reversals. Traders chasing APUS for a third consecutive morning face elevated mean-reversion risk.

The bottom line

This morning's premarket list spans the full spectrum of move types: a genuine earnings-driven explosion (INLF), a textbook acquisition premium (MGLD), a partnership catalyst on a previously volatile name (AIFF), a bounce off a dilution-driven collapse (JAGX), and a momentum continuation with no clear fresh catalyst (APUS). Understanding why a stock is moving is just as important as knowing that it's moving.

A few honest reminders before the 9:30 AM ET open:

• Premarket volume is thin. Prices quoted before the open are on far fewer shares than regular session trading. Spreads are wider, and moves can reverse sharply once institutional and retail order flow floods in at the open.
• Big one-day and multi-day gainers frequently give back substantial portions of their gains. Chasing a stock that is already up 30–120% in premarket is a high-risk strategy, even when the catalyst is real.
• Dilution is a real and lasting headwind. JAGX's share offerings do not disappear because the stock bounces one morning.
• Momentum without a catalyst (see APUS) is the riskiest of all. When traders are the only buyers, the music can stop at any moment.

StockSetups scans the full ~12,300-stock US universe every premarket morning — detecting chart patterns, flagging catalysts, and ranking setups by conviction score — so you can walk into every open knowing exactly which names are moving and why. As always, nothing here is financial advice. Do your own research, size positions according to your risk tolerance, and use stop-losses.